Case 3: POETIC and ADAPT Trials in HR High-Risk Breast Cancer | Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
Case 3: POETIC and ADAPT Trials in HR High-Risk Breast Cancer | Targ…
Mar 14, 2022
targetedonc.com
Dr O’Shaughnessy on the Impetus for the ELEGANT Study in High-Risk Breast Cancer | OncLive
Dr O’Shaughnessy on the Impetus for the ELEGANT Study in High-Ri…
3 months ago
onclive.com
Dr. O'Shaughnessy on the Utility of Capivasertib in Targeting Akt in Breast Cancer | OncLive
Dr. O'Shaughnessy on the Utility of Capivasertib in Targeting Akt in Br…
Mar 9, 2020
onclive.com
Dr O’Shaughnessy on the Utility of the MammaPrint Assay in HR Breast Cancer | OncLive
2:35
Dr O’Shaughnessy on the Utility of the MammaPrint Assay in HR Brea…
8 months ago
onclive.com
The HER2-Positive Breast Cancer Landscape | CancerNetwork
The HER2-Positive Breast Cancer Landscape | CancerNetwork
Oct 7, 2022
cancernetwork.com
Dr O’Shaughnessy on Highly Anticipated Breast Cancer Data to Watch at ESMO 2025 | OncLive
0:56
Dr O’Shaughnessy on Highly Anticipated Breast Cancer Data to …
7 months ago
onclive.com
DESTINY-Breast04: T-DXd in HER2-Low Metastatic Breast Cancer | Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
DESTINY-Breast04: T-DXd in HER2-Low Metastatic Breast Cancer | Ta…
Sep 11, 2023
targetedonc.com
2:02:17
HER2-Low and HER2-Ultralow Breast Cancer — A Roundtable Di…
32 viewsFeb 15, 2025
YouTubeResearch To Practice
1:39
HR+ Metastatic Breast Cancer Treatment Sea Change
92 viewsApr 29, 2019
YouTubeTargeted Oncology
2:00
After losing her mom to breast cancer, Amy Zicarelli faced her ow…
6 months ago
linkedin.com
3:16
MammaPrint: A 70-Gene Signature Test for Patient with Breast Cance…
Feb 8, 2024
onclive.com
1:00
Join us as we scrub in for a chat about the future of women’s canc…
151.2K viewsSep 25, 2023
FacebookMary Kay Global
1:56
Joyce O’Shaughnessy, MD: Treatment Goals for Patients With …
583 viewsMar 31, 2016
YouTubeTargeted Oncology
2:09
Dr. O'Shaughnessy on Using Phosphoprotein Assays to Person…
149 viewsAug 21, 2015
YouTubeOncLive
3:04
Optimizing CDK4/6 Inhibition in HR+ Breast Cancer
80 viewsAug 31, 2018
YouTubeOncLive
2:28
Expert Discusses Promise of Abemaciclib for Breast Cancer Tre…
599 viewsMay 31, 2017
YouTubeTargeted Oncology
16:01
What is inflammatory breast cancer? Patient Jennifer Cordts ta…
14.6K viewsFeb 28, 2023
YouTubeWFAA
2:10
Fact or Fiction w/Dr. O: Can exercise reduce your risk or recurrence of …
70 viewsFeb 21, 2021
YouTubebreastcancercanstick
1:44
Dr. O'Shaughnessy Discusses Negative TNBC Iniparib Trial Results
483 viewsAug 23, 2011
YouTubeOncLive
16:27
ESMO 2019: Dr. O'Shaughnessy Highlights Progress in Breast Can…
611 viewsOct 18, 2019
YouTubeOncLive
24:31
Experts Discuss the Role of CDK4/6 Inhibitors in HR+/HER2- Breast Ca…
34 views7 months ago
YouTubeDecera Clinical Education
1:09:24
Raising the Bar in HR+/HER2- Early Breast Cancer: CDK4 and 6 Inhibit…
2.5K viewsApr 4, 2022
YouTubePeerView Oncology
1:35
Dr. O'Shaughnessy on the Future of Breast Cancer Treatment
780 viewsSep 9, 2011
YouTubeOncLive
Dr. O'Shaughnessy on the Future of TNBC Treatment | OncLive
Sep 15, 2011
onclive.com
2:40
Local oncologist making medical history, leading clinical trials
Mar 12, 2025
nbcdfw.com
26:08
Metastatic Hormone Positive Breast Cancer | 2023 KU Breast Cancer Y…
5.2K viewsMar 24, 2023
YouTubeTotal Health Oncology
2:51
Heterogeneity of Metastatic HR+ Breast Cancer
226 viewsMay 3, 2018
YouTubeOncLive
1:06
plasmaMATCH Findings Play an Important Role in the Breast Canc…
129 viewsApr 30, 2020
YouTubeTargeted Oncology
Meeting an Unmet Need in the Treatment of Early Breast Cancer
Apr 24, 2023
medscape.com
See more videos
Static thumbnail place holder